版本:
中国

BRIEF-Chromadex announces worldwide patent license and research agreement with the Scripps Research Institute

June 12 Chromadex Corp

* Chromadex announces an exclusive worldwide patent license and research agreement with the Scripps Research Institute to identify the potential role of Niagen in treating breast cancer

* ‍Has signed a new, exclusive patent license and research agreement with Scripps Research Institute​ Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐